5 news items
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's IND Gains FDA Clearance For Clinical Use (UPDATED)
VANI
13 Jun 24
potentially offering annual dosing.
Dr. Mendelsohn stated that the findings from the study would also benefit their main project, NPM-115, aimed
Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
VANI
28 May 24
potential benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables. Medication
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
VANI
13 May 24
in development for chronic weight management, with the added potential benefit of once-yearly administration
Vivani Medical to Present at TIDES Conference 2024
VANI
9 May 24
. These NanoPortal implants are designed to provide patients with the opportunity to realize the full potential benefit of their medication by avoiding
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
VANI
26 Mar 24
in development for chronic weight management, with the added potential benefit of once-yearly administration. In March, we raised funding to support
- Prev
- 1
- Next